Epstein Secrets

heart disease. CHOL/HDLC RATIO 8.4 H NON HDL CHOLESTEROL 186 H Target for non-HDL cholesterol is 30 mg/dL higher than LDL cholesterol target. HS CRP 0.8 Lower relative cardiovascular risk according to AHA/CDC guidelines. For ages >17 hs-CRP mg/L <1.0 1.0-3.0 3.1-10.0 >10.0 Years: Risk A

/uL 15-500 cells/uL 0-200 cells/uL VITAMIN B12 439 200-1100 pg/mL C-REACTIVE PROTEIN 0.12 <0.80 mg/dL Please be advised that patients taking Carboxypenicillins may exhibit falsely decreased C-Reactive Protein levels due to an analytical interference in this assay. CORTISOL, TOTAL 20.2 mcg/dL Reference

ease. CHD or with CHOL/HDLC RATIO 4.8 NON HDL CHOLESTEROL 113 Target for non-HDL cholesterol is 30 mg/dL higher than LDL cholesterol target. HS CRP 0.9 Lower relative cardiovascular risk according to Ama/cnc guidelines. FOr ages >17 ha-CRP mg/L <1.0 1.0-3.0 3.1-10.0 >10.0 Years: Risk A

RBC SQUAMOUS EPITHELIAL CELLS BACTERIA HYALINE CAST VITAMIN B12 C-REACTIVE PROTEIN <0.10 <0.80 mg/dL Please be advised that patients taking Carboxypenicillins may exhibit falsely decreased C-Reactive Protein levels due to an analytical interference in this assay. PROLACTIN 3.0 2.0-18.0 ng/m1, MI TEST

ease. CHD or with CHOL/HDLC RATIO 4.8 NON HDL CHOLESTEROL 113 Target for non-HDL cholesterol is 30 mg/dL higher than LDL cholesterol target. HS CRP 0.9 Lower relative cardiovascular risk according to Ama/cnc guidelines. FOr ages >17 ha-CRP mg/L <1.0 1.0-3.0 3.1-10.0 >10.0 Years: Risk A

RBC SQUAMOUS EPITHELIAL CELLS BACTERIA HYALINE CAST VITAMIN B12 C-REACTIVE PROTEIN <0.10 <0.80 mg/dL Please be advised that patients taking Carboxypenicillins may exhibit falsely decreased C-Reactive Protein levels due to an analytical interference in this assay. PROLACTIN 3.0 2.0-18.0 ng/m1, MI TEST